513 related articles for article (PubMed ID: 26270676)
21. Nanomedicine-mediated cancer stem cell therapy.
Shen S; Xia JX; Wang J
Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
[TBL] [Abstract][Full Text] [Related]
22. Cancer stem cells: progress and challenges in lung cancer.
Templeton AK; Miyamoto S; Babu A; Munshi A; Ramesh R
Stem Cell Investig; 2014; 1():9. PubMed ID: 27358855
[TBL] [Abstract][Full Text] [Related]
23. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
24. Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics.
Bhal S; Kundu CN
Med Oncol; 2023 Jan; 40(2):82. PubMed ID: 36662310
[TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide inhibits the growth of cancer stem cells derived from small cell lung cancer by downregulating stem cell-maintenance factors and inducing apoptosis via the Hedgehog signaling blockade.
Chang KJ; Yin JZ; Huang H; Li B; Yang MH
Transl Lung Cancer Res; 2020 Aug; 9(4):1379-1396. PubMed ID: 32953511
[TBL] [Abstract][Full Text] [Related]
26. Update on immune-based therapy strategies targeting cancer stem cells.
Izadpanah A; Mohammadkhani N; Masoudnia M; Ghasemzad M; Saeedian A; Mehdizadeh H; Poorebrahim M; Ebrahimi M
Cancer Med; 2023 Sep; 12(18):18960-18980. PubMed ID: 37698048
[TBL] [Abstract][Full Text] [Related]
27. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in drug delivery systems for targeting cancer stem cells.
Duan H; Liu Y; Gao Z; Huang W
Acta Pharm Sin B; 2021 Jan; 11(1):55-70. PubMed ID: 33532180
[TBL] [Abstract][Full Text] [Related]
29. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.
Wang R; Wei J; Zhang S; Wu X; Guo J; Liu M; Du K; Xu J; Peng L; Lv Z; You W; Xiong Y; Fu Z
Oncotarget; 2016 Dec; 7(52):86816-86828. PubMed ID: 27894099
[TBL] [Abstract][Full Text] [Related]
30. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
[TBL] [Abstract][Full Text] [Related]
31. Regulation of breast cancer stem cell features.
Czerwinska P; Kaminska B
Contemp Oncol (Pozn); 2015; 19(1A):A7-A15. PubMed ID: 25691826
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer stem cells-origin, characteristics and therapy.
Prabavathy D; Swarnalatha Y; Ramadoss N
Stem Cell Investig; 2018; 5():6. PubMed ID: 29682513
[TBL] [Abstract][Full Text] [Related]
33. Immunotargeting of Cancer Stem Cells.
Köseer AS; Di Gaetano S; Arndt C; Bachmann M; Dubrovska A
Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900399
[TBL] [Abstract][Full Text] [Related]
34. A concise review on the current understanding of pancreatic cancer stem cells.
Vaz AP; Ponnusamy MP; Seshacharyulu P; Batra SK
J Cancer Stem Cell Res; 2014; 2():. PubMed ID: 26451384
[TBL] [Abstract][Full Text] [Related]
35. New insight into hedgehog signaling in hematological malignancies.
Geng L; Wang X
Leuk Lymphoma; 2015 Apr; 56(4):858-65. PubMed ID: 24991722
[TBL] [Abstract][Full Text] [Related]
36. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
Clara JA; Monge C; Yang Y; Takebe N
Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
[TBL] [Abstract][Full Text] [Related]
37. The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia.
Wu A; Turner KA; Woolfson A; Jiang X
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986819
[TBL] [Abstract][Full Text] [Related]
38. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract][Full Text] [Related]
39. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.
Aramini B; Masciale V; Grisendi G; Bertolini F; Maur M; Guaitoli G; Chrystel I; Morandi U; Stella F; Dominici M; Haider KH
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205721
[TBL] [Abstract][Full Text] [Related]
40. LncRNA-cCSC1 modulates cancer stem cell properties in colorectal cancer via activation of the Hedgehog signaling pathway.
Zhou H; Xiong Y; Peng L; Wang R; Zhang H; Fu Z
J Cell Biochem; 2020 Mar; 121(3):2510-2524. PubMed ID: 31680315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
